Animal drug compounding trends shaping personalized veterinary treatments and healthcare innovation
Animal drug compounding has emerged as a critical segment within veterinary healthcare, addressing the limitations of commercially available medications. It involves the customized preparation of pharmaceuticals tailored to specific animal species, sizes, and medical conditions. This capability is particularly valuable in cases where standard drugs are unavailable, discontinued, or unsuitable due to dosage or formulation constraints. Technological advancements are significantly enhancing compounding practices. Automated compounding systems, sterile processing environments, and precision dosing technologies are improving consistency, safety, and scalability. Digital prescription management systems and electronic health records are also enabling better coordination between veterinarians and compounding pharmacies, reducing errors and enhancing treatment outcomes. The global animal drug compounding market size was estimated at USD 1.68 billion in 2025 and is projected to...